Details of the Drug

General Information of Drug (ID: DMAAHOF)

• Drug Name: Anti-SARS-CoV-2 REGN-COV2 vaccine

Indication

Disease Entry	ICD 11	Status	REF
Coronavirus Disease 2019 (COVID-19)	1D6Y	Investigative	[1]

• Drug Type: Vaccine
• Cross-matching ID: TTD ID: D0H1WT

References

• [1] Regeneron begins first clinical trials of anti-viral antibody cocktail regn-cov2 for the treatment and prevention of COVID-19. June 11, 2020.